PT - JOURNAL ARTICLE AU - Nils Mueller-Kronast AU - Michael T Froehler AU - Reza Jahan AU - Osama Zaidat AU - David Liebeskind AU - Jeffrey L Saver ED - , TI - Impact of EMS bypass to endovascular capable hospitals: geospatial modeling analysis of the US STRATIS registry AID - 10.1136/neurintsurg-2019-015593 DP - 2020 Nov 01 TA - Journal of NeuroInterventional Surgery PG - 1058--1063 VI - 12 IP - 11 4099 - http://jnis.bmj.com/content/12/11/1058.short 4100 - http://jnis.bmj.com/content/12/11/1058.full SO - J NeuroIntervent Surg2020 Nov 01; 12 AB - Background Routing patients directly to endovascular capable centers (ECCs) would decrease time to mechanical thrombectomy (MT), but may delay intravenous thrombolysis (IVT).Objective To study the clinical outcomes of patients with a stroke transferred directly to ECCs compared with those transferred to ECCs from non-endovascular capable centers (nECCs).Methods Data from the STRATIS registry were analyzed to evaluate process and clinical outcomes under five routing policies: (1) transport to nearest nECC; (2) transport to STRATIS ECC over any distance or (3) within 20 miles; (4) transport to ideal ECC (iECC), over any distance or (5) within 20 miles.Results Among 236 patients, 117 (49.6%) were transferred by ground, of whom 62 (53%) were transferred within 20 miles. Median MT start time was accelerated in all direct transport models. IVT start was prolonged with direct transport across all distances, but accelerated with direct transport to iECC ≤20 miles. With bypass limited to ≤20 miles, the median modeled EMS arrival to IVT interval decreased for both iECCs and ECCs (by 12 min and 6 min, respectively), and median EMS arrival to puncture time decreased by up to 94 min. In this cohort, no patient would have become ineligible for IVT. Bypass to iECC modeling under 20 miles showed a significant reduction in the level of disability at 3 months, with freedom from disability (modified Rankin Scale score 0–1) at 3 months increased by 12%.Conclusions Direct routing of patients with a large vessel occlusion to ECCs, especially when within 20 miles, may lead to better clinical outcomes by accelerating the start of MT without any delay of IVT.Clinical trial registration number http://www.clinicaltrials.gov. Unique identifier: NCT02239640.